Healthcare provider profile · identity verified

Muhammad Kamaluddin Syed, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · OKEECHOBEE, FL · NPI 1447440342

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Muhammad Kamaluddin Syed, M.D. received $89.76 in general payments during 2025 across 4 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 34.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 213 claims for Jardiance by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 290 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$89.76

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$30.67	34.2%	1	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$24.22	27.0%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$18.33	20.4%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$16.54	18.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$89.76	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$30.67	1	2025
Source payment records 2025-02-14 · Boehringer Ingelheim Pharmaceuticals, Inc. · $30.67 · Open Payments source
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$24.22	1	2025
Source payment records 2025-06-26 · Abbott Laboratories · $24.22 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$18.33	1	2025
Source payment records 2025-11-16 · Novo Nordisk Inc · $18.33 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$16.54	1	2025
Source payment records 2025-05-27 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $16.54 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	213	exact normalized	Medicare Part D
Ozempic ozempic	2025	Ozempic	2024	290	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	213	67
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	290	83
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	16	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	1362	437
Atorvastatin Calcium	Atorvastatin Calcium	1171	410
Levothyroxine Sodium	Levothyroxine Sodium	1024	305
Amlodipine Besylate	Amlodipine Besylate	916	316
Rosuvastatin Calcium	Rosuvastatin Calcium	878	298
Metoprolol Succinate	Metoprolol Succinate	831	279
Metformin Hcl	Metformin Hcl	743	251
Gabapentin	Gabapentin	727	239
Omeprazole	Omeprazole	727	239
Pantoprazole Sodium	Pantoprazole Sodium	682	204
Methylprednisolone	Methylprednisolone	579	423
Tamsulosin Hcl	Tamsulosin Hcl	562	183
Lisinopril	Lisinopril	550	193
Furosemide	Furosemide	547	200
Simvastatin	Simvastatin	485	153
Metoprolol Tartrate	Metoprolol Tartrate	420	128
Potassium Chloride	Potassium Chloride	420	157
Clopidogrel	Clopidogrel Bisulfate	416	141
Meloxicam	Meloxicam	407	152
Carvedilol	Carvedilol	368	126
Mounjaro	Tirzepatide	359	79
Sertraline Hcl	Sertraline Hcl	346	107
Azithromycin	Azithromycin	341	263
Eliquis	Apixaban	326	115
Tramadol Hcl	Tramadol Hcl	311	125
Alprazolam	Alprazolam	302	90
Glimepiride	Glimepiride	290	89
Montelukast Sodium	Montelukast Sodium	290	96
Ozempic	Semaglutide	290	83
Albuterol Sulfate Hfa	Albuterol Sulfate	287	112
Famotidine	Famotidine	258	89
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	256	123
Lorazepam	Lorazepam	250	77
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	244	74
Trazodone Hcl	Trazodone Hcl	231	74
Pravastatin Sodium	Pravastatin Sodium	216	70
Duloxetine Hcl	Duloxetine Hcl	213	61
Jardiance	Empagliflozin	213	67
Escitalopram Oxalate	Escitalopram Oxalate	211	66
Nifedipine Er	Nifedipine	209	61
Allopurinol	Allopurinol	205	73
Spironolactone	Spironolactone	203	65
Atenolol	Atenolol	195	67
Temazepam	Temazepam	195	41
Buspirone Hcl	Buspirone Hcl	190	60
Hydralazine Hcl	Hydralazine Hcl	188	50
Warfarin Sodium	Warfarin Sodium	188	39
Mirtazapine	Mirtazapine	186	61
Citalopram Hbr	Citalopram Hydrobromide	168	47
Bumetanide	Bumetanide	160	50
Fluticasone Propionate	Fluticasone Propionate	160	81
Glipizide	Glipizide	158	49
Xarelto	Rivaroxaban	154	41
Diazepam	Diazepam	152	53
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	142	55
Prednisone	Prednisone	138	77
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	131	42
Zolpidem Tartrate	Zolpidem Tartrate	131	39
Propranolol Hcl	Propranolol Hcl	126	42
Ropinirole Hcl	Ropinirole Hcl	126	35
Ezetimibe	Ezetimibe	125	44
Fenofibrate	Fenofibrate	125	36
Quetiapine Fumarate	Quetiapine Fumarate	121	34
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	114	42
Fluoxetine Hcl	Fluoxetine Hcl	110	34
Hydrochlorothiazide	Hydrochlorothiazide	110	43
Tizanidine Hcl	Tizanidine Hcl	110	38
Torsemide	Torsemide	110	41
Bupropion Xl	Bupropion Hcl	109	36
Clonazepam	Clonazepam	108	31
Tresiba Flextouch U-100	Insulin Degludec	104	29
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	101	37
Ibuprofen	Ibuprofen	94	49
Baclofen	Baclofen	90	23
Glipizide Er	Glipizide	89	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	30
Ondansetron Odt	Ondansetron	87	55
Ciprofloxacin Hcl	Ciprofloxacin Hcl	85	71
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	85	30
Oxycodone Hcl	Oxycodone Hcl	83	16
Donepezil Hcl	Donepezil Hcl	81	27
Celecoxib	Celecoxib	79	30
Isosorbide Mononitrate Er	Isosorbide Mononitrate	77	31
Clonidine Hcl	Clonidine Hcl	76	26
Finasteride	Finasteride	76	32
Pregabalin	Pregabalin	75	30
Entresto	Sacubitril/Valsartan	74	20
Diclofenac Sodium	Diclofenac Sodium	73	41
Synthroid	Levothyroxine Sodium	73	20
Lovastatin	Lovastatin	72	26
Novolog Flexpen	Insulin Aspart	72	30
Testosterone Cypionate	Testosterone Cypionate	72	26
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	70	37
Vitamin D2	Ergocalciferol (Vitamin D2)	69	25
Acetaminophen-Codeine	Acetaminophen With Codeine	68	36
Paroxetine Hcl	Paroxetine Hcl	68	23
Alendronate Sodium	Alendronate Sodium	67	26
Hydroxyzine Hcl	Hydroxyzine Hcl	66	40
Symbicort	Budesonide/Formoterol Fumarate	65	20
Doxycycline Hyclate	Doxycycline Hyclate	64	57
Fluconazole	Fluconazole	64	49
Estradiol	Estradiol	62	22
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	62	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	61	53
Methocarbamol	Methocarbamol	61	17
Aripiprazole	Aripiprazole	60	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	21
Sucralfate	Sucralfate	56	19
Bupropion Hcl Sr	Bupropion Hcl	55	17
Esomeprazole Magnesium	Esomeprazole Magnesium	55	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	18
Farxiga	Dapagliflozin Propanediol	54	15
Amitriptyline Hcl	Amitriptyline Hcl	53	14
Valsartan	Valsartan	53	22
Carbidopa-Levodopa	Carbidopa/Levodopa	52	17
Clindamycin Hcl	Clindamycin Hcl	52	45
Enalapril Maleate	Enalapril Maleate	51	15
Fenofibrate	Fenofibrate Nanocrystallized	51	17
Tresiba Flextouch U-200	Insulin Degludec	51	20
Cefdinir	Cefdinir	50	37
Repatha Sureclick	Evolocumab	50	15
Venlafaxine Hcl Er	Venlafaxine Hcl	50	21
Benazepril Hcl	Benazepril Hcl	49	13
Levetiracetam	Levetiracetam	49	14
Solifenacin Succinate	Solifenacin Succinate	49	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	48	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Digoxin	Digoxin	46	18
Triamcinolone Acetonide	Triamcinolone Acetonide	44	34
Oxybutynin Chloride	Oxybutynin Chloride	43	18
Dicyclomine Hcl	Dicyclomine Hcl	42	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	15
Primidone	Primidone	42	16
Linzess	Linaclotide	41	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	40	16
Myrbetriq	Mirabegron	37	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	36	12
Tradjenta	Linagliptin	36	suppressed
Irbesartan	Irbesartan	34	11
Memantine Hcl	Memantine Hcl	34	14
Olmesartan Medoxomil	Olmesartan Medoxomil	34	12
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	34	13
Carisoprodol	Carisoprodol	33	suppressed
Ibandronate Sodium	Ibandronate Sodium	32	13
Meclizine Hcl	Meclizine Hcl	32	16
Ventolin Hfa	Albuterol Sulfate	32	16
Amiodarone Hcl	Amiodarone Hcl	31	14
Januvia	Sitagliptin Phosphate	31	12
Oxybutynin Chloride Er	Oxybutynin Chloride	31	13
Topiramate	Topiramate	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Mupirocin	Mupirocin	30	19
Labetalol Hcl	Labetalol Hcl	29	11
Metolazone	Metolazone	29	15
Nitroglycerin	Nitroglycerin	29	16
Doxepin Hcl	Doxepin Hcl	27	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	27	suppressed
Metformin Hcl Er	Metformin Hcl	26	11
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Diltiazem Hcl	Diltiazem Hcl	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	23	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Fluocinonide	Fluocinonide	21	15
Jantoven	Warfarin Sodium	21	suppressed
Lidocaine	Lidocaine	21	11
Droplet Pen Needle	Pen Needle, Diabetic	20	13
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Metronidazole	Metronidazole	19	15
Naproxen	Naproxen	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Amoxicillin	Amoxicillin	17	14
Cholestyramine	Cholestyramine (With Sugar)	17	12
Gemfibrozil	Gemfibrozil	17	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	17	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	16	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Invokana	Canagliflozin	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Kerendia	Finerenone	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Methimazole	Methimazole	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Enbrel Sureclick	Etanercept	14	suppressed
Gemtesa	Vibegron	14	suppressed
Nystatin	Nystatin	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Alprazolam Er	Alprazolam	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Ofloxacin	Ofloxacin	13	13
Phenobarbital	Phenobarbital	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Vraylar	Cariprazine Hcl	12	suppressed
Azathioprine	Azathioprine	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$89.76 · 4 records	Boehringer Ingelheim Pharmaceuticals, Inc.	CAPLYTA, FREESTYLE LIBRE 3, JARDIANCE, Ozempic	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error